TriangleNCT00392444 · OUTCOME
Objective Response (Partial and Complete) Per RECIST
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- Up to 3 years
What was measured
Number of patients who had objective responses after radiology review
Analysis population: 1 cancelled patient and 4 ineligible patients were excluded from analysis.
Groups in this outcome
Treatment (Sunitinib Malate)
Patients receive oral sunitinib malate once daily on days 1-28. Treatment repeats every 6 weeks in the absence of disease progression or unacceptable toxicity.
| Group | Source count |
|---|---|
| Treatment (Sunitinib Malate) | 35 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Treatment (Sunitinib Malate) | 1 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 1
- denoms
- counts
- group Id
- OG000
- value
- 35
- units
- Participants
- description
- Number of patients who had objective responses after radiology review
- groups
- description
- Patients receive oral sunitinib malate once daily on days 1-28. Treatment repeats every 6 weeks in the absence of disease progression or unacceptable toxicity.
- id
- OG000
- title
- Treatment (Sunitinib Malate)
- param Type
- NUMBER
- population Description
- 1 cancelled patient and 4 ineligible patients were excluded from analysis.
- reporting Status
- POSTED
- time Frame
- Up to 3 years
- title
- Objective Response (Partial and Complete) Per RECIST
- type
- PRIMARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice